Obituary for Guy de Thé by unknown
de Thé and Gessain Retrovirology  (2015) 12:7 
DOI 10.1186/s12977-014-0128-2OBITUARY Open AccessObituary for Guy de Thé
Hugues de Thé1* and Antoine Gessain2*Guy de Thé, MD, PhD, passed away on August 7, 2014,
aged 84. He had obtained his MD in Marseille, as a resi-
dent in haematology/Oncology. He then undertook a
PhD, which he defended in 1967, partly in France at the
Centre National de la Recherche Scientifique (CNRS)
in Villejuif, and in the US, working at Duke University
with J. Beard and at the National Cancer Institute with
R. Bryan. He then became head of the Biological Carci-
nogene unit at the International Agency for Cancer
Research in Lyon up to 1978. He then directed a CNRS
laboratory in Lyon and, finally created the Unit of
Epidemiology of Oncogenic Viruses at the Institut
Pasteur in 1990. After his official retirement in 1997, he
actively engaged into academic life, notably at an inter-
national level, with the Inter Academy Medical Panel.
He was affiliated with the French Academy of Science,
of Medicine, the American Institute for Medicine and
the Chinese Academy of Preventive Medicine. He has
been one of the founders and the President of the Inter-
national Association for Retrovirology HTLV.
Guy de Thé devoted his research efforts to the onco-
genic viruses, particularly in developing countries that
pay a high toll to these pathogens. His approaches were
particularly broad, ranging from electron microscopy
imaging, classic virology, immuno-virology, up to field
epidemiology and even anthropology. He trained during
all his life, spending multiples stays in the US (Duke,
Harvard, NCI), England (Oxford), as well as in China.
Early on, he had chosen viruses, especially herpes-
viruses and retroviruses, as the entry point for cancer
biology. A passionate advocate for research, ready to
take many challenges, he initiated many projects that
bridged field and laboratory work, particularly in Africa* Correspondence: Hugues.dethe@inserm.fr; antoine.gessain@pasteur.fr
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article, unless otherwise stated.and Southern China. He was a pioneer in EBV research,
prospectively demonstrating, in a very large study per-
formed in Uganda, the key role of early EBV activation
in Burkitt's lymphoma [1] (Figure 1). He also pioneered
the field of EBV and nasopharyngeal carcinoma (NPC)
[2]. Beside some important genetic studies [3], he dem-
onstrated, through large collaboration with Chinese
colleagues, that EBV reactivation could be used to pre-
dict the development of NPC [4,5]. Finally, while the
relationship between retroviral infections and neurode-
generative diseases are well known in animals, he was
the first one to demonstrate that HTLV-I infection can
drive a chronic and severe neurological condition
(Tropical Spastic Paraparesis) frequent in HTLV-1 en-
demic areas [6,7].
Author of over 300 scientific publications, Guy was
also a talented writer, author of many books for the gen-
eral public in the context of the origin and prevention of
cancer. He also organized and was the chairman of sev-
eral important internationl symposium on mainly onco-
genic viruses, especially EBV and HTLV-1.
Guy was an enthusiastic man, always looking for novel
clues linking viruses and diseases, anywhere in the
world. He had close friends all over the world, notably in
China, where he was one of the first French Scientists to
establish effective collaborations with Chinese scholars
as early as 1977. He trained numerous young researchers
and always gave a chance to those who knew how to
grab it. His colleagues depict him as a kind, elegant and
benevolent man, interested in the discoveries and suc-
cesses of others. He also had a passion for art, in which
he hoped to find the same intrinsic beauties as in bio-
logical systems. His friends and family deeply miss him.Central. This is an Open Access article distributed under the terms of the
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Figure 1 Guy de Thé in Institut Pasteur Paris in the early 1990’s, showing a map of Africa where the Burkitt prospective study
took place.
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